iRhythm Technologies NASDAQ: IRTC executives said the company is seeing continued business momentum after a favorable Medicare coverage update, a stronger-than-expected first quarter and progress on several product and margin initiatives.
iRhythm Holdings, Inc. (IRTC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
The consensus price target hints at a 57.2% upside potential for IRHYTHM HLDGS (IRTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.
iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.95 per share a year ago.
iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the outlook.
Cinctive Capital Management LP acquired a new stake in shares of iRhythm Technologies (NASDAQ: IRTC) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 28,044 shares of the company's stock, valued at approximately $4,823,000. Cinctive Capital Management LP owned about 0.09%
iRhythm Holdings, Inc. (IRTC) Q4 2025 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago.
IRHYTHM HLDGS (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.